<DOC>
	<DOCNO>NCT01516138</DOCNO>
	<brief_summary>The purpose study evaluate effect modify glucose - insulin - potassium ( GIK ) therapy cardiac surgery patient undergo cardiopulmonary bypass ( CPB ) .</brief_summary>
	<brief_title>Benefits GIK Cardiac Surgery Patients</brief_title>
	<detailed_description>Cardiopulmonary bypass ( CPB ) necessary technique maintain circulation cardiac surgery . But CPB associate series problem organ , hyperglycemia induce neuroendocrine stress . The research show hyperglycemia induced stress would cause worsened hospital outcome patient undergoing cardiac surgery . Intraoperative postoperative glucose control beneficial patient . It 40 year since first application glucose - insulin - potassium ( GIK ) cardiac surgery clinical application GIK show controversial result . The beginning time application ratio glucose insulin may key reason controversy . In pilot trial 40 valve replacement case , find perioperative treatment GIK insulin-glucose ratio 1:3 show beneficial effect heart surgery . Therefore , investigator plan continue test modify GIK regimen heart surgery patient determine whether GIK may cardioprotective effect patient undergo CPB surgery . Myocardial biopsy biological mechanism analysis perform prior CPB , 15 min aortic cross clamp application 15 min reperfusion small cohort . Myocardial biopsy snap frozen fix .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Between 18 70 year age Elective cardiac surgery first time cardiopulmonary bypass Left ventricular ejection fraction ( LVEF ) â‰¥ 30 % Informed agreement sign Previous cardiac surgery Emergent surgery Cardiac surgery without use cardiopulmonary bypass Diabetes mellitus Severe renal insufficiency Severe respiratory insufficiency Serious preoperative illness ( sepsis , active infection active malignancy require treatment ) Pregnant woman positive pregnancy test History drug abuse Subject history bleed diathesis , coagulopathy , refuse blood transfusion Enrollment another clinical study Lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Glucose-insulin-potassium</keyword>
	<keyword>Cardiac surgery</keyword>
</DOC>